Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NOVONIXFRA:GC3 -3.88%37 Days Sales Outstanding is 0.00 as of Jun. 2026. GuruFocus rates FRA:GC3 with a GF Score™ of 37/100. The stock has 4 warning signs investors should review. Among 3,041 Industrial Products companies, NOVONIX ranks worse than 32883.89% on this metric.
NOVONIX's average Accounts Receivable for the
six
months ended in Jun. 2026 was €3.89 Mil. NOVONIX's Revenue for the
six
months ended in Jun. 2026 was €0.00 Mil.
The historical rank and industry rank for NOVONIX's Days Sales Outstanding or its related term are showing as below:
During the past 9 years, NOVONIX's highest Days Sales Outstanding was 1010.43. The lowest was 66.64. And the median was 99.58.
FRA:GC3's Days Sales Outstanding is not ranked *
in the Industrial Products industry.
Industry Median: 80.79 * Ranked among companies with meaningful Days Sales Outstanding only.
NOVONIX's Days Sales Outstanding
stayed the same
from Jun. 2025 (0.00) to Jun. 2026 (0.00).
NOVONIX (FRA:GC3) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
NOVONIX Days Sales Outstanding Related Terms
NOVONIX Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for NOVONIX's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:GC3 vs VRT, BE: Days Sales Outstanding Comparison
For the Electrical Equipment & Parts subindustry, NOVONIX's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NOVONIX Days Sales Outstanding vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, NOVONIX's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where NOVONIX's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NOVONIX (FRA:GC3) has a Days Sales Outstanding of 0.00 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on NOVONIX and its competitors. Over the past decade, NOVONIX's Days Sales Outstanding has ranged from 66.64 to 1,010.43. According to the industry distribution chart, NOVONIX ranks #999999 out of 3041 companies in the Industrial Products industry.
Is NOVONIX's Days Sales Outstanding too high?
NOVONIX's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 66.64 to a high of 1,010.43. Based on the distribution chart, NOVONIX ranks #999999 out of 3041 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, NOVONIX has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does NOVONIX's Days Sales Outstanding compare to VRT and BE?
According to the Industrial Products industry distribution chart, NOVONIX ranks #999999 out of 3041 companies for Days Sales Outstanding. This places NOVONIX in the lower half of its industry. The industry median Days Sales Outstanding is 80.79. Historically, NOVONIX's own Days Sales Outstanding has ranged from 66.64 to 1,010.43 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for an Industrial Products company?
The median Days Sales Outstanding among Industrial Products companies is 80.79, based on 3,041 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on NOVONIX and its competitors. For the Industrial Products industry, the median Days Sales Outstanding is 80.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NOVONIX's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NOVONIX stock overvalued right now?
NOVONIX (FRA:GC3) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. NOVONIX's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For NOVONIX (FRA:GC3), the current Days Sales Outstanding is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.
37GF Score
Get the complete analysis for FRA:GC3
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GC3 has been successfully added to your 
